Korean J Gastroenterol.  2015 Oct;66(4):245-247. 10.4166/kjg.2015.66.4.245.

Effect of Amitriptyline in Patients with Functional Dyspepsia

• Jo Y

• KMID: 2373350
• DOI: http://doi.org/10.4166/kjg.2015.66.4.245

Abstract

No abstract available.

MeSH Terms

Amitriptyline/*therapeutic use
Antidepressive Agents, Tricyclic/*therapeutic use
Citalopram/*therapeutic use
Dyspepsia/*drug therapy
Female
Humans
Male
*Quality of Life
Serotonin Uptake Inhibitors/*therapeutic use
Amitriptyline
Antidepressive Agents, Tricyclic
Citalopram
Serotonin Uptake Inhibitors

Reference

References

1. Talley NJ, Locke GR, Saito YA, et al. Effect of amitriptyline and escitalopram on functional dyspepsia: a multicenter, randomized controlled study. Gastroenterology. 2015; 149:340–349. e2.

2. Levy RL, Olden KW, Naliboff BD, et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology. 2006; 130:1447–1458.

3. Mertz H, Fass R, Kodner A, Yan-Go F, Fullerton S, Mayer EA. Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol. 1998; 93:160–165.

4. Braak B, Klooker TK, Wouters MM, Lei A, van den Wijngaard RM, Boeckxstaens GE. Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double-blind placebo-controlled study. Aliment Pharmacol Ther. 2011; 34:638–648.

5. Tan VP, Cheung TK, Wong WM, Pang R, Wong BC. Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study. World J Gastroenterol. 2012; 18:6127–6133.

6. van Kerkhoven LA, Laheij RJ, Aparicio N, et al. Effect of the anti-depressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. 2008; 6:746–752.

7. Grover M, Camilleri M. Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases. J Gastroenterol. 2013; 48:177–181.

8. Lacy BE, Talley NJ, Locke GR 3rd, et al. Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther. 2012; 36:3–15.

9. Tack J, Janssen P, Masaoka T, Farré R, Van Oudenhove L. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. Clin Gastroenterol Hepatol. 2012; 10:1239–1245.

10. Parkman HP, Van Natta ML, Abell TL, et al. Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trial. JAMA. 2013; 310:2640–2649.

11. Dekel R, Drossman DA, Sperber AD. The use of psychotropic drugs in irritable bowel syndrome. Expert Opin Investig Drugs. 2013; 22:329–339.

12. Wang YP, Chen YT, Tsai CF, et al. Short-term use of serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding. Am J Psychiatry. 2014; 171:54–61.

13. De Picker L, Van Den Eede F, Dumont G, Moorkens G, Sabbe BG. Antidepressants and the risk of hyponatremia: a class-by-class review of literature. Psychosomatics. 2014; 55:536–547.